Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 10 695 / https://doi.org/10.3332/ecancer.2016.695

Research

Research engagement among black men with prostate cancer

Background: Black men are three times more likely to develop prostate cancer (PCa) and often present with more aggressive disease. Nevertheless, black men are consistently underrepresented in research studies. We aimed to get more insight into the reasons for this reduced recruitment, as it is important for future research to include results that are also applicable to black men with PCa.

Methods: Two focus groups (n = 10 and n = 6) of black males currently under treatment for PCa at Guys Hospital, London, UK were held to gather information regarding the understanding of and exposure to research, as well as the barriers and facilitators for recruitment into research studies.

Results: Barriers to recruitment included; mistrust of researchers, lack of understanding of the research process and the mechanisms of PCa and a reliance on herbal medicine. Suggested facilitators for recruitment improvement included thorough explanations of the research process, media advertisement and word of mouth. Financial incentives were also discussed but received mixed reception.

Conclusion: We uncovered a number of barriers to recruitment of black men with PCa into research and accompanying strategies for improving involvement. Many are consistent with the literature, emphasising that current efforts have not been successful in ameliorating the concerns of the black community. Beliefs in herbal medicine and aversion to financial incentives appear to be novel themes, and so further insight into these issues could prove beneficial.

Keywords: prostate cancer, black ethnicity, consent

Loading Article Metrics ... Please wait

Author interviews

Mieke Van Hemelrijck

King's College London, UK

Related articles

Special Issue: Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.898

Special Issue: Barriers in Latin America for the management of locally advanced breast cancer

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.897

Special Issue: Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.896

Special Issue: Locally advanced breast cancer in Brazil: current status and future perspectives

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.895

Special Issue: Locally advanced breast cancer in young women in Latin America

Abstract | Full Article | PDF | Spanish Published: 22 Jan 2019 / https://doi.org/10.3332/ecancer.2019.894



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation